• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension.

作者信息

Lajoie Annie Christine, Bonnet Sebastien, Provencher Steeve

机构信息

Pulmonary Hypertension Research Group, Laval University, Quebec City, QC G1V 4G5, Canada; Institut Universitaire de Cardiologie et de Pneumologie de Québec Research Center, Laval University, Quebec City, QC G1V 4G5, Canada.

Pulmonary Hypertension Research Group, Laval University, Quebec City, QC G1V 4G5, Canada; Institut Universitaire de Cardiologie et de Pneumologie de Québec Research Center, Laval University, Quebec City, QC G1V 4G5, Canada; Department of Medicine, Laval University, Quebec City, QC G1V 4G5, Canada.

出版信息

Lancet Respir Med. 2017 Jul;5(7):544-546. doi: 10.1016/S2213-2600(17)30223-0.

DOI:10.1016/S2213-2600(17)30223-0
PMID:28664855
Abstract
摘要

相似文献

1
Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension.聚焦临床试验研究：改善肺动脉高压的药物研发与试验设计
Lancet Respir Med. 2017 Jul;5(7):544-546. doi: 10.1016/S2213-2600(17)30223-0.
2
Building the case for novel clinical trials in pulmonary arterial hypertension.为肺动脉高压新型临床试验提供依据。
Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):114-23. doi: 10.1161/CIRCOUTCOMES.114.001319.
3
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives.肺动脉高压的终点指标与临床试验设计：临床及监管视角
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):48S-55S. doi: 10.1016/j.jacc.2004.02.010.
4
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.2012年心房颤动导管消融与外科消融专家共识声明：患者选择、手术技术、患者管理与随访、定义、终点及研究试验设计的建议
Europace. 2012 Apr;14(4):528-606. doi: 10.1093/europace/eus027. Epub 2012 Mar 1.
5
Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.骨科静脉血栓栓塞症预防试验中的出血定义：标准化的迫切需求。
Thromb Res. 2012 Oct;130 Suppl 1:S32. doi: 10.1016/j.thromres.2012.08.268.
6
Trial design for metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌的试验设计
J Clin Oncol. 2008 Jul 20;26(21):3647-8; author reply 3648-9. doi: 10.1200/JCO.2008.17.1140.
7
End points and clinical trial design in pulmonary arterial hypertension.肺动脉高压的终点指标与临床试验设计
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-S107. doi: 10.1016/j.jacc.2009.04.007.
8
Heart failure: Heart failure clinical trials: how do we define success?心力衰竭：心力衰竭临床试验：我们如何定义成功？
Nat Rev Cardiol. 2013 Sep;10(9):492-4. doi: 10.1038/nrcardio.2013.115. Epub 2013 Aug 6.
9
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?肺动脉高压的终点指标与临床试验设计：我们取得进展了吗？
Eur Respir J. 2009 Jul;34(1):231-42. doi: 10.1183/09031936.00107108.
10
Exercise as an end-point in pulmonary hypertension trials.运动作为肺动脉高压试验的一个终点指标。
Int J Clin Pract Suppl. 2010 Jan(165):4-6. doi: 10.1111/j.1742-1241.2009.02231.x.